BIO Urges FDA To Maintain Its Independence For COVID-19 Decisions

In an open letter published Thursday (Sept. 3) , the Biotechnology Innovation Organization urges FDA to maintain its independence as the “gold-standard” regulatory body, and for politics to stay out of the development and approval of new medicines so the public can rest assured any vaccine or therapy that comes to market has undergone a rigorous review process and has been upheld to the “highest standards of scientific and medical integrity.” The organization also calls for companies to make sure...